207 related articles for article (PubMed ID: 19437039)
1. Cisplatin-based chemotherapy for advanced seminoma: report of 52 cases treated in two institutions.
Giannis M; Aristotelis B; Vassiliki K; Ioannis A; Konstantinos S; Nikolaos A; Georgios P; Georgios P; Pantelis P; Meletios-Athanasios D
J Cancer Res Clin Oncol; 2009 Nov; 135(11):1495-500. PubMed ID: 19437039
[TBL] [Abstract][Full Text] [Related]
2. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.
Garcia-del-Muro X; Maroto P; Gumà J; Sastre J; López Brea M; Arranz JA; Lainez N; Soto de Prado D; Aparicio J; Piulats JM; Pérez X; Germá-Lluch JR
J Clin Oncol; 2008 Nov; 26(33):5416-21. PubMed ID: 18936476
[TBL] [Abstract][Full Text] [Related]
4. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of metastatic seminoma by chemotherapy.: an experience].
Komatsubara S; Itoi T; Watanabe M; Kitamura Y; Koike T
Nihon Hinyokika Gakkai Zasshi; 2000; 91(10-11):666-72. PubMed ID: 11109817
[TBL] [Abstract][Full Text] [Related]
6. An alternative treatment regimen of advanced seminoma with carboplatin, etoposide, and bleomycin instead of cisplatin-based therapy.
Giesen E; Mager A; van Tinteren H; Rodenhuis S; Kerst JM
Urol Oncol; 2013 Jan; 31(1):110-4. PubMed ID: 21458311
[TBL] [Abstract][Full Text] [Related]
7. E400P in advanced seminoma of good prognosis according to the international germ cell cancer collaborative group (IGCCCG) classification: the Spanish Germ Cell Cancer Group experience.
Arranz Arija JA; García del Muro X; Gumà J; Aparicio J; Salazar R; Saenz A; Carles J; Sánchez M; Germà-Lluch JR
Ann Oncol; 2001 Apr; 12(4):487-91. PubMed ID: 11398880
[TBL] [Abstract][Full Text] [Related]
8. Residual mass following chemotherapy of seminoma.
Horwich A; Paluchowska B; Norman A; Huddart R; Nicholls J; Fisher C; Husband J; Dearnaley DP
Ann Oncol; 1997 Jan; 8(1):37-40. PubMed ID: 9093705
[TBL] [Abstract][Full Text] [Related]
9. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group.
Fosså SD; Droz JP; Stoter G; Kaye SB; Vermeylen K; Sylvester R
Br J Cancer; 1995 Mar; 71(3):619-24. PubMed ID: 7880748
[TBL] [Abstract][Full Text] [Related]
11. The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis.
Cullen M; Huddart R; Joffe J; Gardiner D; Maynard L; Hutton P; Mazhar D; Shamash J; Wheater M; White J; Goubar A; Porta N; Witts S; Lewis R; Hall E;
Eur Urol; 2020 Mar; 77(3):344-351. PubMed ID: 31901440
[TBL] [Abstract][Full Text] [Related]
12. Two cycles of cisplatin-based chemotherapy for low-volume stage II seminoma: results of a retrospective, single-center case series.
Pichler R; Leonhartsberger N; Stöhr B; Horninger W; Steiner H
Chemotherapy; 2012; 58(5):405-10. PubMed ID: 23296381
[TBL] [Abstract][Full Text] [Related]
13. [Management of advanced seminoma: retrospective study of 96 patients].
Bompas E; Fléchon A; Biron P; Droz JP
Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
[TBL] [Abstract][Full Text] [Related]
14. A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.
Fizazi K; Delva R; Caty A; Chevreau C; Kerbrat P; Rolland F; Priou F; Geoffrois L; Rixe O; Beuzeboc P; Malhaire JP; Culine S; Aubelle MS; Laplanche A
Eur Urol; 2014 Feb; 65(2):381-6. PubMed ID: 24094847
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy intensification in patients with advanced seminoma and adverse prognostic factors.
Fedyanin M; Tryakin A; Bulanov A; Vybarava A; Tjulandina A; Chekini D; Sekhina O; Figurin K; Garin A; Tjulandin S
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1259-64. PubMed ID: 25586890
[TBL] [Abstract][Full Text] [Related]
16. [Testis germ cell tumours: which chemotherapy, for which patients?].
Fléchon A; Droz JP
Ann Urol (Paris); 2007 Apr; 41(2):56-67. PubMed ID: 17486913
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy treatment planning for testicular seminoma.
Wilder RB; Buyyounouski MK; Efstathiou JA; Beard CJ
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e445-52. PubMed ID: 22436787
[TBL] [Abstract][Full Text] [Related]
18. Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
Aparicio J; García Del Muro X; Maroto P; Terrasa J; Castellano D; Bastús R; Gumà J; Sagastibeltza N; Durán I; Ochenduszko S; Meana JA; García-Sánchez J; Arranz JA; Gironés R; Germà JR
Clin Transl Oncol; 2021 Jan; 23(1):58-64. PubMed ID: 32462393
[TBL] [Abstract][Full Text] [Related]
19. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
20. Treatment in germ cell tumours: state of the art.
Tjan-Heijnen VC; Oosterhof GO; de Wit R; De Mulder PH
Eur J Surg Oncol; 1997 Apr; 23(2):110-7. PubMed ID: 9158183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
